Clinical Trial Update: Impact of GLP-1 Receptor Agonists on Patients With IPMN

View source ↗

Summary

A clinical trial is evaluating the impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasm of the pancreas. The study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraductal Papillary Mucinous Neoplasm of the Pancreas

Drugs mentioned

• GLP-1 receptor agonists

Snippet

Sponsor: Hôpital Fribourgeois | Conditions: IPMN, IPMN, Pancreatic | Status: NOT_YET_RECRUITING